CDKN2A and melanoma: Most cases of hereditary melanoma are due to mutations in cyclin-dependent kinase inhibitor 2A (CDKN2A), but other additional susceptibility genes, such as CDK4, TERT, ACD, TERF2IP, POT1, MITF, MC1R, and BAP1, have been identified recently [39].